- Home
- NOTV vs ORGN Comparison
NOTV vs ORGN Comparison
Compare NOTV & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- ORGN
- Stock Information
- Founded
- NOTV 1974
- ORGN 2008
- Country
- NOTV United States
- ORGN United States
- Employees
- NOTV N/A
- ORGN N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- ORGN Major Chemicals
- Sector
- NOTV Health Care
- ORGN Industrials
- Exchange
- NOTV Nasdaq
- ORGN Nasdaq
- Market Cap
- NOTV 128.0M
- ORGN 149.2M
- IPO Year
- NOTV 1997
- ORGN N/A
- Fundamental
- Price
- NOTV $4.06
- ORGN $0.97
- Analyst Decision
- NOTV Strong Buy
- ORGN Strong Buy
- Analyst Count
- NOTV 3
- ORGN 1
- Target Price
- NOTV $5.92
- ORGN $3.00
- AVG Volume (30 Days)
- NOTV 701.6K
- ORGN 1.7M
- Earning Date
- NOTV 02-05-2025
- ORGN 03-13-2025
- Dividend Yield
- NOTV N/A
- ORGN N/A
- EPS Growth
- NOTV N/A
- ORGN N/A
- EPS
- NOTV N/A
- ORGN N/A
- Revenue
- NOTV $475,114,000.00
- ORGN $35,123,000.00
- Revenue This Year
- NOTV $6.37
- ORGN $10.27
- Revenue Next Year
- NOTV $5.74
- ORGN $80.25
- P/E Ratio
- NOTV N/A
- ORGN N/A
- Revenue Growth
- NOTV N/A
- ORGN 123.12
- 52 Week Low
- NOTV $1.23
- ORGN $0.44
- 52 Week High
- NOTV $11.42
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- NOTV 49.10
- ORGN 51.38
- Support Level
- NOTV $3.58
- ORGN $0.81
- Resistance Level
- NOTV $4.51
- ORGN $1.12
- Average True Range (ATR)
- NOTV 0.42
- ORGN 0.07
- MACD
- NOTV 0.01
- ORGN 0.02
- Stochastic Oscillator
- NOTV 43.08
- ORGN 52.01
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others.